MA

Masimo CorpNASDAQ MASI Stock Report

Last reporting period 29 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

6.151

Middle

Exchange

XNAS - Nasdaq

MASI Stock Analysis

MA

Avoid

Based on Eyestock quantitative analysis, MASI`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

30/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-24.7 %

Overvalued

Market cap $B

6.151

Dividend yield

Shares outstanding

52.602 B

Masimo Corporation is a global technology company that develops and produces a range of industry monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. Its patient monitoring solutions incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer partners. It has developed Masimo Signal Extraction Technology, which provides the capabilities of Measure-through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Its technology offerings also include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet and others.

View Section: Eyestock Rating